Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model
使用新型临床前模型确定三阴性乳腺癌的易感位点
基本信息
- 批准号:10573287
- 负责人:
- 金额:$ 40.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAggressive behaviorAntigensBioinformaticsBody Weight decreasedBreast Cancer ModelBreast Cancer PatientBreast Cancer cell lineCancer BurdenCandidate Disease GeneClinicalCombined Modality TherapyComputing MethodologiesDataData SetDatabasesDietDiseaseEnvironmentFDA approvedFamilyGene ModifiedGenerationsGenesGeneticGenetic HeterogeneityGenetic ModelsGenetic Predisposition to DiseaseGenetic VariationGenetically Engineered MouseGenomeGenomicsGoalsHeritabilityHeterogeneityHigh Fat DietHumanHuman GeneticsHybridsImmunologyImmunotherapyImpairmentIn VitroInbreedingIndividualIndividual DifferencesInvestigationLinkMediatingMethodsModelingMolecularMusNeoplasm MetastasisObesityOutcomePaclitaxelPathologyPatient CarePatient-Focused OutcomesPatientsPhenotypePilot ProjectsPliabilityPopulationPre-Clinical ModelPredispositionQuantitative Trait LociRecombinantsReproducibilityResearch PersonnelResourcesRiskRisk FactorsSamplingSeveritiesSusceptibility GeneSystemTranslatingTreatment EfficacyValidationVariantWeightWeight GainWorkanti-PD-L1breast cancer genomicsbreast cancer progressioncancer therapycandidate validationcausal variantchemotherapyfallsgene conservationgene environment interactiongene networkgenetic analysisgenetic approachgenetic resourcegenetic variantgenome sequencinggenome wide association studygenomic variationimmune checkpoint blockadeimprovedin vivoinnovationlead candidatemalignant breast neoplasmmouse modelneoplasm resourcenovelpersonalized medicinepre-clinicalsegregationtargeted treatmenttraittransplant modeltreatment responsetriple-negative invasive breast carcinomatumortumor initiationwhole genome
项目摘要
SUMMARY:
The lack of understanding how genetic variants affect molecular mechanisms that mediate TNBC aggression
and impact effective anti-tumor therapies poses a substantial obstacle to advancement in cancer therapies.
Current genetically engineered mouse models (GEMMs) of TNBC lack genetic complexity because mice are
on a single inbred background which impairs the rigorous investigation into how individual genetic variation
might impact tumor initiation, progression, or response to therapy. Because of this limitation, pre-clinical
models typically fail to translate well to impact patient care. Although human studies have identified risk factors
for developing TNBC with both environmental and genetics approaches, studies often fall short due to the
inability to control variables or sample enough individuals. To address these limitations, we have pioneered a
transformative approach with the creation of a novel murine model with robust, reliable, and reproducible
phenotypic and genomic variation. We systematically crossed the C3(1)-Tantigen (C3Tag) GEMM, well
established to resemble human basal-like TNBC, into the BXD family - the largest and best characterized
genetic reference population. Preliminary data demonstrate that BXD-TNBC F1 isogenic hybrids have greatly
differing severity of TNBC phenotypes, indicating genetic modifiers that impact disease. The advantage of the
BXD-TNBC hybrids is that every genome is defined and reproducible. Using cutting edge systems genetics
and molecular candidate validation, we will identify genetic modifiers of TNBC. Cross-species comparisons
with publicly available human GWAS and genomic databases will identify conserved, biologically relevant, and
targetable candidates to yield highly impactful and readily translatable findings. We hypothesize that the
interaction of modifier and causal genes govern the heterogeneity of TNBC phenotypes and alter response to
therapy. Aim 1 will identify and validate novel genetic modifiers of TNBC phenotypes through unbiased
systematic quantification of TNBC severity and heritability across BXD-TNBC hybrids. Pilot studies revealed
candidate genes that impact patient survival in TNBC. Aim 2 will identify and validate novel genetic modifiers of
therapeutic efficacy across BXD-TNBC hybrids. Last, the genetic contribution linking obesity and TNBC is
currently unknown which is a problem because obesity exacerbates poor BC outcomes and reduces
therapeutic efficacy in patients. Aim 3 will identify genetic modifiers of susceptibility to obesity exacerbated
TNBC. Capitalizing upon our team’s expertise, the overall objective is to interrogate this replicable genetic
resource using established successful strategies to inform on the genetics of human risk and response to
therapy. In sum, the lack of targeted therapies for TNBC presents a great unmet clinical need. The deliverables
of this novel BXD-TNBC will define susceptibility loci, candidate genes, and molecular networks that underlie
variation of multiple TNBC phenotypes. Results generated will thus be transformative with high impact, leading
to the identification of genes modifying heterogeneity and networks underlying individual differences in TNBC.
总结:
缺乏对遗传变异如何影响介导TNBC攻击的分子机制的理解
有效的抗肿瘤治疗对癌症治疗的进展构成了实质性的障碍。
目前的TNBC基因工程小鼠模型(GEMM)缺乏遗传复杂性,因为小鼠是
在一个单一的近亲繁殖的背景,这损害了严格的调查,如何个人遗传变异,
可能影响肿瘤的发生、进展或对治疗的反应。由于这种局限性,临床前
模型通常不能很好地转化以影响患者护理。虽然人类研究已经确定了风险因素
对于用环境和遗传学方法开发TNBC,研究往往由于
无法控制变量或对足够的个体进行采样。为了解决这些局限性,我们开创了一种
通过建立一种新的小鼠模型,
表型和基因组变异。我们系统地将C3(1)-Tantigen(C3 Tag)GEMM杂交,
建立类似于人类基底细胞样TNBC,进入BXD家族-最大和最好的表征
遗传参考群体初步数据表明,BXD-TNBC F1同基因杂种具有很大的遗传多样性。
TNBC表型的不同严重程度,表明影响疾病的遗传修饰剂。的优势
BXD-TNBC杂交是每个基因组是定义和可重复的。利用尖端系统遗传学
和分子候选物验证,我们将鉴定TNBC的遗传修饰物。跨物种比较
与公开可用的人类GWAS和基因组数据库将确定保守的,生物学相关的,
有针对性的候选人,以产生高度影响力和易于翻译的结果。我们假设
修饰基因和致病基因的相互作用控制TNBC表型的异质性,并改变对TNBC的应答。
疗法目的1将通过无偏的方法鉴定和验证TNBC表型的新型遗传修饰剂。
在BXD-TNBC杂种中系统量化TNBC严重性和遗传性。试点研究显示,
影响TNBC患者生存率的候选基因。目标2将确定和验证新的遗传修饰剂,
在BXD-TNBC混合物中的治疗功效。最后,将肥胖和TNBC联系起来的遗传贡献是
目前尚不清楚这是一个问题,因为肥胖加剧了BC结果不佳,
患者的治疗效果。目标3将确定遗传修饰的易感性肥胖加剧
TNBC。利用我们团队的专业知识,总的目标是审问这个可复制的基因
资源使用既定的成功战略,以告知人类风险的遗传学和应对
疗法总之,TNBC靶向疗法的缺乏提出了很大的未满足的临床需求。可交付成果
这种新的BXD-TNBC将定义易感基因座,候选基因和分子网络,
多种TNBC表型的变异。因此,所产生的成果将具有变革性和高影响力,
涉及修饰TNBC个体差异的异质性和网络的基因的鉴定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liza Makowski-Hayes其他文献
Liza Makowski-Hayes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liza Makowski-Hayes', 18)}}的其他基金
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.
确定微生物衍生的代谢物对肥胖驱动的癌症风险中的保护性免疫的贡献。
- 批准号:
10505372 - 财政年份:2022
- 资助金额:
$ 40.47万 - 项目类别:
Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model
使用新型临床前模型确定三阴性乳腺癌的易感位点
- 批准号:
10444546 - 财政年份:2022
- 资助金额:
$ 40.47万 - 项目类别:
Role of microbial-modulated bile acid receptor signaling in breast cancer
微生物调节胆汁酸受体信号传导在乳腺癌中的作用
- 批准号:
10404525 - 财政年份:2020
- 资助金额:
$ 40.47万 - 项目类别:
Role of microbial-modulated bile acid receptor signaling in breast cancer
微生物调节胆汁酸受体信号传导在乳腺癌中的作用
- 批准号:
10053592 - 财政年份:2020
- 资助金额:
$ 40.47万 - 项目类别:
Role of microbial-modulated bile acid receptor signaling in breast cancer
微生物调节胆汁酸受体信号传导在乳腺癌中的作用
- 批准号:
10219210 - 财政年份:2020
- 资助金额:
$ 40.47万 - 项目类别:
Role of microbial-modulated bile acid receptor signaling in breast cancer
微生物调节胆汁酸受体信号传导在乳腺癌中的作用
- 批准号:
10614037 - 财政年份:2020
- 资助金额:
$ 40.47万 - 项目类别:
(PQA2) Reversing Carcinogenic Effect of Obesity on Basal-like Breast Cancer
(PQA2) 逆转肥胖对基底样乳腺癌的致癌作用
- 批准号:
8590946 - 财政年份:2013
- 资助金额:
$ 40.47万 - 项目类别:
Macrophage Mitochondrial Stress in Inflammation, Insulin Resistance & Obesity
炎症、胰岛素抵抗中的巨噬细胞线粒体应激
- 批准号:
8208231 - 财政年份:2007
- 资助金额:
$ 40.47万 - 项目类别:
Macrophage Mitochondrial Stress in Inflammation, Insulin Resistance & Obesity
炎症、胰岛素抵抗中的巨噬细胞线粒体应激
- 批准号:
8121191 - 财政年份:2007
- 资助金额:
$ 40.47万 - 项目类别:
Macrophage Mitochondrial Stress in Inflammation, Insulin Resistance & Obesity
炎症、胰岛素抵抗中的巨噬细胞线粒体应激
- 批准号:
7479191 - 财政年份:2007
- 资助金额:
$ 40.47万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists